CMS and FDA introduce ACCESS and TEMPO models to enable digital health device integration in traditional Medicare, focusing on outcome-aligned payments, regulatory easing, and expanded patient access.

Explore Medicare coverage guidelines for Botox focusing on FDA-approved medical uses, prior authorization, medical necessity, and cost factors under Medicare Part B and Advantage plans.

Medicare costs including Part B premiums, Part A deductible, and coinsurance rates rise in 2026, impacting retiree budgets and Social Security benefits.

Explore how IRMAA impacts Medicare premiums for higher-income beneficiaries and its significance for U.S. healthcare insurance and compliance professionals.

CMS introduces the ACCESS Model, a voluntary Medicare Part B demonstration offering Outcome-Aligned Payments for technology-enhanced chronic care. The model supports providers managing chronic conditions like diabetes and hypertension, emphasizing care coordination and outcome-based reimbursement.

Medicare beneficiaries face higher Part B premiums, fewer Part D plans, and Medicare Advantage cancellations in 2026, making open enrollment critical for coverage decisions.

Medicare in 2026 will see notable premium hikes, fewer prescription drug plans, and changes in Medicare Advantage availability. Understand the impact on coverage choices and costs to prepare for open enrollment.

Medicare 2026 premiums surge nearly 10%, with fewer Medicare Advantage plans as insurers scale back. Explore key Medicare cost drivers and market impacts.

CMS's 2026 proposed rules for Medicare Part B include major updates to average sales price calculations, Inflation Reduction Act compliance, ASP documentation, and Medicare inflation rebates affecting government pricing.

Explore critical Medicare enrollment deadlines, coverage coordination with FEHB, and plan options for federal retirees to optimize benefits and manage costs.